Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.
about
Interventions for bronchiectasis: an overview of Cochrane systematic reviewsProlonged antibiotics for non-cystic fibrosis bronchiectasis in children and adultsDevelopment of Liposomal Ciprofloxacin to Treat Lung InfectionsClinical applications of pulmonary delivery of antibioticsPrimary ciliary dyskinesia.Bronchiectasis in the Last Five Years: New DevelopmentsInhaled Antibiotics for Gram-Negative Respiratory InfectionsThe EMBARC European Bronchiectasis Registry: protocol for an international observational studyBronchiectasis and Aspergillus: How are they linked?What's new in the management of adult bronchiectasis?Bronchiectasis in COPD patients: more than a comorbidity?Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with BronchiectasisGenetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.Developing drug therapies in bronchiectasis.Emerging drugs for bronchiectasis: an update.Challenges in the development of new therapies for bronchiectasis.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.An update on pediatric bronchiectasis.Pediatric bronchiectasis: No longer an orphan disease.The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis.Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.Bronchiectasis: Phenotyping a Complex Disease.Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.Diagnosis and management of bronchiectasis.Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis.Virulence Adaptations of Pseudomonas aeruginosa Isolated from Patients with Non-Cystic Fibrosis Bronchiectasis.Update in Bronchiectasis 2014.Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non-Cystic Fibrosis Bronchiectasis and the Significance of Mycobacterium abscessus subsp. abscessus Isolation during M. avium Complex Lung Disease Therapy.The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease.Reclaiming the name 'bronchiectasis'.The pharmacological treatment of bronchiectasis.Aerosolized Antibiotics for Patients with Bronchiectasis."The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study.
P2860
Q24186645-EC306336-0DCE-4A39-9DD3-00C6160FF8C5Q24187890-E6BB155E-7326-47B8-BABB-91EBE574CF9FQ26764772-5B5D1B50-7A0E-4C22-BB82-70F25839781AQ26996053-F4E96462-9CE9-4CFE-8F8D-00462F257043Q27333212-493814A5-91AE-48B2-A8B0-0CD57FF958BAQ28075732-7CCAC430-570A-4EE0-9FDF-0C3CF4C71922Q28386160-777C971B-2C89-4948-83A5-5DC87057EDF4Q28596688-089785A1-9007-4931-868F-A9A3ABC1C110Q30243947-B6DAE171-258F-4FCE-AFCD-E93D97436D40Q33589288-4E39D1D2-FCFB-49C2-8863-66549EC6D3BBQ33704105-19461563-76CA-4A5F-8C59-B64636BAB404Q33755342-E0F41C63-9B24-4B1E-97A4-1AD8C12C633EQ35764823-EAC3F060-AAF1-4B09-A49F-C0A5D804CBE1Q36692961-CFEB8692-35CF-4704-8C97-66DC677C7A93Q37471610-0F712C62-D316-4FEB-AA8F-9F5FEA1BF1D6Q37613743-E6774E66-74E3-4562-9A8F-610EF094C723Q38259329-0E532AAC-FC9E-45D7-BC33-5B3F80025587Q38367379-0967AC87-3369-40DA-9B92-E1552712A267Q38387657-03EF3D52-A4DB-4813-BC78-ACBB3826C59CQ38569772-5D52A6D8-FE2F-4831-BE20-CA00BCEA3740Q38679480-EB55F0F1-82C0-4A36-A81D-7000624AC3BCQ38721361-84659D89-6B47-4DF7-8744-A2946838DA51Q38730670-1B33FD03-0E30-4802-81FA-373140A234B3Q38797806-522CB4A5-A153-4127-82BC-E5A1218A8BD0Q38901227-D5D38D5E-FB33-4584-B147-3C17810AC9D4Q38923436-2917806D-6313-4F20-B79A-C4F46B88D65FQ39384458-DC5C9851-58BF-47AE-A6BE-11798F4EDF0FQ40106308-E393448C-C435-45C2-AA68-091909E267D7Q40429705-2DE57C15-DB17-4BA9-99AE-B1FCF7F489D5Q41122996-A6F96C5A-B984-4A2F-B7C8-45458B5024F7Q41129323-35E2963C-5B36-444D-A9A7-7E178C140AC3Q41615902-3FD60BA8-0E94-4271-8034-9AC647C438E7Q41697766-4BB041D4-DF25-4579-8485-1A8588FDC65CQ47730320-83EFDCAA-A53F-4397-8672-E7E2E2FC189CQ47788593-F84A4746-7E48-4551-8C76-D0684BC2E15BQ51648266-01F9E97F-5CD9-4206-A4DD-35AEBA7F361AQ51751531-3AB80B6F-B55F-4E66-A60F-F40A7CDB9D78Q52983978-A628F457-D2A2-41C2-8C1E-3A863089A550Q55350869-6CC8609E-CDDE-4634-9B14-51E381B1594D
P2860
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Aztreonam for inhalation solut ...... ebo-controlled phase 3 trials.
@en
Aztreonam for inhalation solut ...... ebo-controlled phase 3 trials.
@nl
type
label
Aztreonam for inhalation solut ...... ebo-controlled phase 3 trials.
@en
Aztreonam for inhalation solut ...... ebo-controlled phase 3 trials.
@nl
prefLabel
Aztreonam for inhalation solut ...... ebo-controlled phase 3 trials.
@en
Aztreonam for inhalation solut ...... ebo-controlled phase 3 trials.
@nl
P2093
P921
P1476
Aztreonam for inhalation solut ...... ebo-controlled phase 3 trials.
@en
P2093
A Bruce Montgomery
Alan F Barker
Alexandra L Quittner
Anne E O'Donnell
David Gossage
Jenny Zhang
Jonathan D Ruzi
Laura Haas
Lixin Shao
Matthew T McKevitt
P304
P356
10.1016/S2213-2600(14)70165-1
P577
2014-08-18T00:00:00Z